AMA hosting town hall on physicians' EHR frustrations

The American Medical Association (AMA) and the Medical Association of Georgia (MAG) are teaming up to host a town hall meeting to give physicians a chance to discuss their concerns about EHRs and looming regulations. Among the national and local leaders who will take part in the conversation are U.S. Representative Tom Price, MD, and AMA President Steven J. Stack, MD.

Although the U.S. government has spent $24.6 billion to promote a digital health infrastructure based on the power of EHRs to enhance patient care, improve productivity and reduce costs and most physicians have adopted the technology, many physicians strongly believe the current course of federal regulations threatens to turn the promise of EHRs into a pipe-dream, according to a release. 

Government requirements have "twisted EHR technology so it interferes with face-to-face discussions with patients, requires physicians to spend too much time performing clerical work and creates new costs that divert resources away from patient care improvements. Meanwhile, the much anticipated benefits of being able to share important patient healthcare information electronically among providers in different settings have gone unfulfilled."

The town hall meeting is scheduled for Monday, July 20 from 7 to 8:30pm at the Westin Atlanta Perimeter North. During the meeting, the AMA also will discuss 

During the live event, the AMA will also discuss its national initiative to reframe federal regulations and encourage better designed EHRs that emphasize high-quality patient care as the primary focus.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.